Standard treatment in advanced ovarian cancer in 2005: the state of the art
Author:
Publisher
BMJ
Subject
Obstetrics and Gynecology,Oncology
Reference49 articles.
1. Pilot Evaluation of High-Dose Carboplatin and Paclitaxel Followed by High-Dose Melphalan Supported by Peripheral Blood Stem Cells in Previously Untreated Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
2. Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group.
3. Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer
4. Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of Obesity on the Pharmacokinetics and Pharmacodynamics of Anticancer Agents;The Journal of Clinical Pharmacology;2023-11
2. Prognostic significance of TM4SF1 and DDR1 expression in epithelial ovarian cancer;Oncology Letters;2023-08-30
3. The challenge of selecting tumor antigens for chimeric antigen receptor T-cell therapy in ovarian cancer;Medical Oncology;2022-09-29
4. High Serpin Family A Member 10 Expression Confers Platinum Sensitivity and Is Associated With Survival Benefit in High-Grade Serous Ovarian Cancer: Based on Quantitative Proteomic Analysis;Frontiers in Oncology;2021-11-23
5. Advances Of Chimeric Antigen Receptor T Cell Therapy In Ovarian Cancer;OncoTargets and Therapy;2019-09
Advances Of Chimeric Antigen Receptor T Cell Therapy In Ovarian Cancer
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3